Taken together, these data suggest that exploitation of the retinol/retinoic acid axis in cisplatin-resistant NSCLC cells may deplete the ALDH1+ve CSC subpopulation to levels comparable with their cisplatin-sensitive counterparts. Here, ALDH1A1 is linked to non-small cell lung carcinoma.